UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prioritizing back injury risk in hospital employees: application and comparison of different injury rates

Journal of occupational and environmental medicine, 2000-06, Vol.42 (6), p.645-652

2000

Volltextzugriff (PDF)

Methods of prioritizing and measuring occupational health risks utilizing hospital back injury data. Development of composite comparative statistics

Journal of occupational and environmental medicine, 1997-09, Vol.39 (9), p.882-888

1997

Volltextzugriff (PDF)

Furosemide overdose and maximal allowable weight standards

Military medicine, 1989-12, Vol.154 (12), p.608-609

1989

Volltextzugriff (PDF)

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Journal of clinical oncology, 2018-04, Vol.36 (11), p.1080-1087

2018

Volltextzugriff (PDF)

Green Salad Intake Is Associated with Improved Oral Cancer Survival and Lower Soluble CD44 Levels

Nutrients, 2021-01, Vol.13 (2), p.372

2021

Volltextzugriff (PDF)

Ethical surgical triage of patients with head and neck cancer during the COVID‐19 pandemic

Head & neck, 2020-07, Vol.42 (7), p.1423-1447

2020

Volltextzugriff (PDF)

The Identification of Senescence-Specific Genes during the Induction of Senescence in Prostate Cancer Cells

Neoplasia (New York, N.Y.), 2005-09, Vol.7 (9), p.816-823

2005

Volltextzugriff (PDF)

Perioperative Blood Transfusion and Radical Cystectomy: Does Timing of Transfusion Affect Bladder Cancer Mortality?

European urology, 2014-12, Vol.66 (6), p.1139-1147

2014

Volltextzugriff (PDF)

APPLICATION OF ATTRITION-MILLED SOY FLOUR IN A BEVERAGE APPLICATION

Journal of food process engineering, 2009-04, Vol.32 (2), p.145-160

2009

Volltextzugriff (PDF)

E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas

Cancer research (Chicago, Ill.), 1995-11, Vol.55 (22), p.5195-5199

1995

Volltextzugriff (PDF)

MetaNetwork Enhances Biological Insights from Quantitative Proteomics Differences by Combining Clustering and Enrichment Analyses

Journal of proteome research, 2022-02, Vol.21 (2), p.410-419

2022

Volltextzugriff (PDF)

Reversible epigenetic alterations regulate class I HLA loss in prostate cancer

Communications biology, 2022-09, Vol.5 (1), p.897-897, Article 897

2022

Volltextzugriff (PDF)

A Novel Biomarker for Staging Human Prostate Adenocarcinoma: Overexpression of Matriptase with Concomitant Loss of its Inhibitor, Hepatocyte Growth Factor Activator Inhibitor-1

Cancer epidemiology, biomarkers & prevention, 2006-02, Vol.15 (2), p.217-227

2006

Volltextzugriff (PDF)

Novel Pathways Associated with Bypassing Cellular Senescence in Human Prostate Epithelial Cells

The Journal of biological chemistry, 2002-04, Vol.277 (17), p.14877-14883

2002

Volltextzugriff (PDF)

Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917

Cancer prevention research (Philadelphia, Pa.), 2011-11, Vol.4 (11), p.1761-1769

2011

Volltextzugriff (PDF)

Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence

Cancer, 2011-06, Vol.117 (12), p.2629-2636

2011

Volltextzugriff (PDF)

p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells

Cancer research (Chicago, Ill.), 1999-06, Vol.59 (12), p.2957-2964

1999

Volltextzugriff (PDF)

Long Noncoding RNAs AC009014.3 and Newly Discovered XPLAID Differentiate Aggressive and Indolent Prostate Cancers

Translational oncology, 2018-06, Vol.11 (3), p.808-814

2018

Volltextzugriff (PDF)

Inducible expression of cancer-testis antigens in human prostate cancer

Oncotarget, 2016-12, Vol.7 (51), p.84359-84374

2016

Volltextzugriff (PDF)

Long term efficacy and QOL data of chemohormonal therapy (C-HT) in low and high volume hormone naïve metastatic prostate cancer (PrCa): E3805 CHAARTED trial

Annals of oncology, 2016-10, Vol.27, p.vi244-vi244

2016

Volltextzugriff (PDF)

Surgical operative time increases the risk of deep venous thrombosis and pulmonary embolism in robotic prostatectomy

Journal of the Society of Laparoendoscopic Surgeons, 2014, Vol.18 (2), p.282-287

2014

Volltextzugriff (PDF)

Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial

European urology oncology, 2020-12, Vol.3 (6), p.717-724

2020

Volltextzugriff (PDF)

Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis

Head & neck, 2016-08, Vol.38 (8), p.1234-1241

2016

Volltextzugriff (PDF)

Eight-year survival rates by baseline prognostic groups in patients with metastatic hormone-sensitive prostate cancer (mHSPC): An analysis from the ECOG-ACRIN 3805 (CHAARTED) trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5081-5081

2022

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(73)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prioritizing back injury risk in hospital employees: application and comparison of different injury rates

Methods of prioritizing and measuring occupational health risks utilizing hospital back injury data. Development of composite comparative statistics

Furosemide overdose and maximal allowable weight standards

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Green Salad Intake Is Associated with Improved Oral Cancer Survival and Lower Soluble CD44 Levels

Ethical surgical triage of patients with head and neck cancer during the COVID‐19 pandemic

The Identification of Senescence-Specific Genes during the Induction of Senescence in Prostate Cancer Cells

Perioperative Blood Transfusion and Radical Cystectomy: Does Timing of Transfusion Affect Bladder Cancer Mortality?

APPLICATION OF ATTRITION-MILLED SOY FLOUR IN A BEVERAGE APPLICATION

E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas

MetaNetwork Enhances Biological Insights from Quantitative Proteomics Differences by Combining Clustering and Enrichment Analyses

Reversible epigenetic alterations regulate class I HLA loss in prostate cancer

A Novel Biomarker for Staging Human Prostate Adenocarcinoma: Overexpression of Matriptase with Concomitant Loss of its Inhibitor, Hepatocyte Growth Factor Activator Inhibitor-1

Novel Pathways Associated with Bypassing Cellular Senescence in Human Prostate Epithelial Cells

Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917

Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence

p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells

Long Noncoding RNAs AC009014.3 and Newly Discovered XPLAID Differentiate Aggressive and Indolent Prostate Cancers

Inducible expression of cancer-testis antigens in human prostate cancer

Long term efficacy and QOL data of chemohormonal therapy (C-HT) in low and high volume hormone naïve metastatic prostate cancer (PrCa): E3805 CHAARTED trial

MP19-16 INCORPORATING PROSTATE MRI IMAGING CHARACTERISTICS TO IMPROVE PROSTATE CANCER DIAGNOSIS AND RISK STRATIFICATION: AN ANALYSIS AND NOMOGRAM DERIVED FROM A 9,536 PATIENT, MULTI-INSTITUTIONAL COHORT

Surgical operative time increases the risk of deep venous thrombosis and pulmonary embolism in robotic prostatectomy

Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial

Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis

Eight-year survival rates by baseline prognostic groups in patients with metastatic hormone-sensitive prostate cancer (mHSPC): An analysis from the ECOG-ACRIN 3805 (CHAARTED) trial

Suchergebnisse filtern